Publication de 6 numéros par an
ISSN Imprimer: 1040-8401
ISSN En ligne: 2162-6472
Indexed in
Therapeutic Dendritic Cell−Based Cancer Vaccines: The State of the Art
RÉSUMÉ
Dendritic cells (DCs) are the most potent professional antigen-presenting cells, capable of initiating proper adaptive immune responses. Although tumor-infiltrating DCs are able to recognize cancer cells and uptake tumor antigens, they often have impaired functions because of the immunosuppressive tumor milieu. Therefore, DCs are targeted by therapeutic means either in vivo or ex vivo to facilitate tumor antigen presentation to T cells and induce or promote efficient antitumor immune responses in cancer patients. This immunotherapeutical approach is defined as specific active tumor immunotherapy or therapeutic cancer vaccination. In this review we briefly discuss general aspects of DC biology, followed by a thorough description of the current knowledge and optimization trends of DC vaccine production ex vivo, including various approaches for the induction of proper DC maturation and efficient loading with tumor antigens. We also discuss critical clinical aspects of DC vaccine application in cancer patients, including protocols of administration (routes and regimens), individualization of tumor immunotherapy, prediction and proper evaluation of immune and clinical responses to immunotherapy, and the critical role of combining tumor immunotherapy with other cancer treatment strategies to achieve maximal therapeutic effects.
-
Kandušer Maša, Ušaj Marko, Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines, Expert Opinion on Drug Delivery, 11, 12, 2014. Crossref
-
Bhanumathy Kalpana, Zhang Bei, Ahmed Khawaja, Qureshi Mabood, Xie Yufeng, Tao Min, Tan Xin, Xiang Jim, Transgene IL-6 Enhances DC-Stimulated CTL Responses by Counteracting CD4+25+Foxp3+ Regulatory T Cell Suppression via IL-6-Induced Foxp3 Downregulation, International Journal of Molecular Sciences, 15, 4, 2014. Crossref
-
Antoniu Sabina Antonela, Dimofte Gabriel, Ungureanu Didona, Immune therapies for malignant mesothelioma, Expert Review of Anticancer Therapy, 14, 8, 2014. Crossref
-
Strioga Marius M., Darinskas Adas, Pasukoniene Vita, Mlynska Agata, Ostapenko Valerijus, Schijns Virgil, Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?, Vaccine, 32, 32, 2014. Crossref
-
Chiu Flora W Y, Bagci Hakan, Fisher Amanda G, deMello Andrew J, Elvira Katherine S, A microfluidic toolbox for cell fusion, Journal of Chemical Technology & Biotechnology, 91, 1, 2016. Crossref
-
Datta Jashodeep, Berk Erik, Cintolo Jessica A., Xu Shuwen, Roses Robert E., Czerniecki Brian J., Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy, Frontiers in Immunology, 6, 2015. Crossref
-
Kazemi Tohid, Younesi Vahid, Jadidi-Niaragh Farhad, Yousefi Mehdi, Immunotherapeutic approaches for cancer therapy: An updated review, Artificial Cells, Nanomedicine, and Biotechnology, 2015. Crossref
-
Meng Lijun, Bai Zhenjiang, He Shan, Mochizuki Kazuhiro, Liu Yongnian, Purushe Janaki, Sun Hongxing, Wang Jian, Yagita Hideo, Mineishi Shin, Fung Henry, Yanik Gregory A., Caricchio Roberto, Fan Xiaoxuan, Crisalli Lisa M., Hexner Elizabeth O., Reshef Ran, Zhang Yanyun, Zhang Yi, The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation, The Journal of Immunology, 196, 3, 2016. Crossref
-
Michalek Jaroslav, Hezova Renata, Turanek-Knötigova Pavlina, Gabkova Jana, Strioga Marius, Lubitz Werner, Kudela Pavol, Oncolysate-loaded Escherichia coli bacterial ghosts enhance the stimulatory capacity of human dendritic cells, Cancer Immunology, Immunotherapy, 66, 2, 2017. Crossref
-
Meng Lijun, Hu Shaoyan, Wang Jian, He Shan, Zhang Yi, DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responses, Pharmacological Research, 113, 2016. Crossref
-
Tian Yuanyuan, Meng Lijun, Zhang Yi, Epigenetic Regulation of Dendritic Cell Development and Function, The Cancer Journal, 23, 5, 2017. Crossref
-
Manzo Emiliano, Cutignano Adele, Pagano Dario, Gallo Carmela, Barra Giusi, Nuzzo Genoveffa, Sansone Clementina, Ianora Adrianna, Urbanek Konrad, Fenoglio Daniela, Ferrera Francesca, Bernardi Cinzia, Parodi Alessia, Pasquale Giuseppe, Leonardi Antonio, Filaci Gilberto, De Palma Raffaele, Fontana Angelo, A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response, Scientific Reports, 7, 1, 2017. Crossref
-
Kraśko Jan Aleksander, Žilionytė Karolina, Darinskas Adas, Strioga Marius, Rjabceva Svetlana, Zalutsky Iosif, Derevyanko Marina, Kulchitsky Vladimir, Lubitz Werner, Kudela Pavol, Miseikyte-Kaubriene Edita, Karaman Olha, Didenko Hennadii, Potebnya Hryhorii, Chekhun Vasyl, Pašukonienė Vita, Bacterial ghosts as adjuvants in syngeneic tumour cell lysate-based anticancer vaccination in a murine lung carcinoma model, Oncology Reports, 37, 1, 2017. Crossref
-
Liu Linying, Mao Zheng, Zhang Jianhua, Liu Na, Liu Qing Huo, Aegerter Christof Markus, The Influence of Vesicle Shape and Medium Conductivity on Possible Electrofusion under a Pulsed Electric Field, PLOS ONE, 11, 7, 2016. Crossref
-
Strioga M.M., Dobrovolskiene N.T., Dendritic Cells as Targets of Vaccines and Adjuvants, in Immunopotentiators in Modern Vaccines, 2017. Crossref
-
Fekete Natalie, Béland Ariane V., Campbell Katie, Clark Sarah L., Hoesli Corinne A., Bags versus flasks: a comparison of cell culture systems for the production of dendritic cell–based immunotherapies, Transfusion, 58, 7, 2018. Crossref
-
Dobrovolskienė N., Pašukonienė V., Darinskas A., Kraśko J.A., Žilionytė K., Mlynska A., Gudlevičienė Ž., Mišeikytė-Kaubrienė E., Schijns V., Lubitz W., Kudela P., Strioga M., Tumor lysate-loaded Bacterial Ghosts as a tool for optimized production of therapeutic dendritic cell-based cancer vaccines, Vaccine, 36, 29, 2018. Crossref
-
Wu Xuejie, Xu Feng, Liu Jinliang, Wang Guiqiang, Comparative study of dendritic cells matured by using IL-1β, IL-6, TNF-α and prostaglandins E2 for different time span, Experimental and Therapeutic Medicine, 14, 2, 2017. Crossref
-
Tel-Karthaus Nina, Kers-Rebel Esther D., Looman Maaike W., Ichinose Hiroshi, de Vries Carlie J., Ansems Marleen, Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function, Frontiers in Immunology, 9, 2018. Crossref
-
Wołkow Paweł P., Gębska Anna, Korbut Ryszard, In vitro maturation of monocyte-derived dendritic cells results in two populations of cells with different surface marker expression, independently of applied concentration of interleukin-4, International Immunopharmacology, 57, 2018. Crossref
-
Ušaj Marko, Kandušer Maša, Modified Adherence Method (MAM) for Electrofusion of Anchorage-Dependent Cells, in Cell Fusion, 1313, 2015. Crossref
-
Yu Hongshuang, Tian Yuanyuan, Wang Ying, Mineishi Shin, Zhang Yi, Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance, Frontiers in Immunology, 10, 2019. Crossref
-
Garnica Omar, Das Kishore, Devasundaram Santhi, Dhandayuthapani Subramanian, Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide, Tuberculosis, 116, 2019. Crossref
-
Silva Mariana, Silva Zélia, Marques Graça, Ferro Tiago, Gonçalves Márcia, Monteiro Mauro, van Vliet Sandra J., Mohr Elodie, Lino Andreia C., Fernandes Alexandra R., Lima Flávia A., van Kooyk Yvette, Matos Teresa, Tadokoro Carlos E., Videira Paula A., Sialic acid removal from dendritic cells improves antigen cross-presentation and boosts anti-tumor immune responses, Oncotarget, 7, 27, 2106. Crossref
-
Kraśko Jan , Žilionytė Karolina , Darinskas Adas , Dobrovolskienė Neringa , Mlynska Agata , Riabceva Svetlana , Zalutsky Iosif , Derevyanko Marina , Kulchitsky Vladimir , Karaman Olga , Fedosova Natalia , Symchych Tatiana , Didenko Gennady , Chekhun Vasyl , Strioga Marius , Pašukonienė Vita , Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model, Oncology Letters, 2018. Crossref
-
Brennick Cory A, George Mariam M, Corwin William L, Srivastava Pramod K, Ebrahimi-Nik Hakimeh, Neoepitopes as cancer immunotherapy targets: key challenges and opportunities, Immunotherapy, 9, 4, 2017. Crossref
-
Chesson Charles B, Zloza Andrew, Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer, Nanomedicine, 12, 23, 2017. Crossref
-
Ruan Shaobo, Greenberg Zachary, Pan Xiaoshu, Zhuang Pei, Erwin Nina, He Mei, Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy, Advanced Healthcare Materials, 11, 5, 2022. Crossref
-
Zakrzewski Johannes L, van den Brink Marcel R M, Hubbell Jeffrey A, Overcoming immunological barriers in regenerative medicine, Nature Biotechnology, 32, 8, 2014. Crossref
-
Li Chengxiang, Ke Qiang, Yao Cheng, Yao Chenguo, Mi Yan, Wu Meng, Ge Liangpeng, Comparison of Bipolar and Unipolar Pulses in Cell Electrofusion: Simulation and Experimental Research, IEEE Transactions on Biomedical Engineering, 66, 5, 2019. Crossref
-
Tőke E R, Lőrincz O, Csiszovszki Z, Somogyi E, Felföldi G, Molnár L, Szipőcs R, Kolonics A, Malissen B, Lori F, Trocio J, Bakare N, Horkay F, Romani N, Tripp C H, Stoitzner P, Lisziewicz J, Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes, Gene Therapy, 21, 6, 2014. Crossref
-
Tian Yuanyuan, Yu Hongshuang, Hu Shaoyan, Zhang Yi, Dendritic Cell-Regulated T Cell Immunity and Tolerance against Acute Myeloid Leukemia, in Advanced Concepts in Human Immunology: Prospects for Disease Control, 2020. Crossref